COVID-19 and hemorrhagic stroke are a deadly combination, increasing the risk of death up to 2.4 times among patients who have this pairing compared to those who only had hemorrhagic strokes, according to a nationwide study ...
Apr 14, 2021
0
12
(HealthDay)—Women with suspected acute coronary syndrome who have low-risk History, Electrocardiogram, Age, Risk factors, and Troponin (HEART) scores have more appropriate testing and better outcomes than men, according ...
Jan 13, 2021
0
5
The use of a standardized tool for assessing the risk of serious outcomes in patients with chest pain was associated with women at high risk receiving comparable care to men, according to new research published in the Annals ...
Dec 23, 2020
0
2
Randomized controlled trials (RCT) of psychotherapeutic interventions have addressed depression and demoralization associated with acute coronary syndromes. The present trial introduces psychological well-being, an increasingly ...
Dec 15, 2020
0
2
About five percent of patients experience heart muscle injury around the time of their surgery for a noncardiac condition, yet guideline recommendations to identify patients at risk using biomarkers are not being followed. ...
Dec 10, 2020
0
8
A new study suggests that COVID-19 guidance in Sweden may have reduced people's risks of having a heart attack.
Dec 3, 2020
0
20
Heart attacks strike suddenly and have a range of different triggers. Researchers from Charité - Universitätsmedizin Berlin and the German Centre for Cardiovascular Research (DZHK) were able to uncover a further underlying ...
Nov 10, 2020
0
1
The OPTIMIZE randomized trial comparing a novel, low-profile drug-eluting stent (DES) facilitating transradial access (TR) and direct stenting (DS) to existing DES did not establish non-inferiority of the new stent based ...
Oct 19, 2020
0
0
A randomized clinical trial found that drug-eluting stents (DES) with durable polymers are non-inferior to DES with biodegradable polymers in patients with acute coronary syndrome (ACS).
Oct 19, 2020
0
2
New data from the PROSPECT II study shows that NIRS-IVUS intracoronary imaging can help identify angiographically non-obstructive lesions with high-risk characteristics for future adverse cardiac outcomes.
Oct 15, 2020
0
1
